期刊文献+

前列腺癌放射治疗临床疗效及毒性的新进展

原文传递
导出
摘要 随着高龄化及生活方式的改变,前列腺癌的发生率逐渐上升[1].放射治疗技术作为其主要治疗方式之一,伴随着计算机技术和放射影像学的发展而不断进步,突出表现为靶区的精确性及照射剂量明显提高,其临床疗效进一步提高,放射性损伤也有一定程度的改善[2-3],但是患者的临床综合获益仍需进一步提高.现将前列腺癌放射治疗的进展综述如下.一、靶区剂量与临床疗效1.三维适形与调强放射治疗:根据常规分割的剂量-效应关系,提高局部剂量有望提高局部控制率.三位适形放射治疗(3D-CRT)代替常规放射治疗,正是由于其可产生更高的靶区照射剂量,而周围危及器官的受量又在可控范围.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第12期2757-2758,共2页 Chinese Journal of Experimental Surgery
基金 河北省科学技术厅支撑计划资助项目(11276103D-34)
  • 相关文献

参考文献17

  • 1王国民,武睿毅.我国前列腺癌实验研究的现状和展望[J].中华实验外科杂志,2005,22(9):1031-1034. 被引量:42
  • 2Morton GC, Loblaw DA, Sankreacha R, et al. Single-fraction high-dose-rate brachy- therapy and hypofractionated external beam radiotherapy' for men with intermedi- ate-risk prostate cancer:analysis of short- and medium-term toxicity and quality of life. Int J Radiat Oncol Biol Phys,2010, 77:811-817. 被引量:1
  • 3Valakh V, Kirichenko A, Miller R, et al. Combination of IG-IMRT and permanent source prostate brachytherapy in patients with organ-confined prostate cancer: GU and GI toxicity and effect on erectile func- tion. Brachytherapy,2011,10 : 195-200. 被引量:1
  • 4Schwarz R. Curative radiotherapy of local- ized prostate cancer. Treatme:at methods and results. Urologe A, 2003,42: 1212- 1220. 被引量:1
  • 5Cahlon O, Zelefsky MJ, Shippy A, et al. Ultra-high dose (86.4Gy) IMRT for lo- calized prostate cancer: toxicity and bio- chemical outcomes. Int J Radiat Oncol Bi- ol Phys,2008 ,71:330-337. 被引量:1
  • 6Liauw SL, Weichselbaum RR, Rash C, et al. Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer. Technol Cancer Rcs Treat, 2009,8 : 201-206. 被引量:1
  • 7Loblaw DA, Cheung P. External beam irra- diation for localized prostate cancer: the promise of hypofractionation. Can J Urol, 2006,13:62-66. 被引量:1
  • 8Pollack A, Hanlon AL, Horwitz EM, et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofraetionation close escalation trial, lnt J Radiat Oncol Biol Phys ,2006,64:518-526. 被引量:1
  • 9Koukourakis MI, Abatzoglou I, Touloupidis S, et al. Biologicaldose volume histogramsduring conformal hypofractionated acceler- ated radiotherapy for prostate cancer. Med Phys ,2007,34:76-80. 被引量:1
  • 10Ritter M. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol, 2008,18:249-256. 被引量:1

二级参考文献26

  • 1刘跃平,刘新帆,李晔雄,金晶,关莹.前列腺癌三维适形放疗中体位对靶区和正常组织体积及照射剂量的影响[J].中华放射肿瘤学杂志,2005,14(5):422-426. 被引量:12
  • 2刘定益 巢志复 何小舟 等.淋巴管造影用于诊断前列腺癌淋巴结转移的初步报告[J].中华肿瘤杂志,1988,1:56-56. 被引量:3
  • 3刘定益 刘定益 主编.淋巴管造影方法[A].刘定益,主编.淋巴造影术[C].南京:江苏科技出版社,1989.25-44. 被引量:4
  • 4Brundage M,Lukka H,Crook J,et al.The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer-a systematic review.Radiother Oncol,2002,64:239-250. 被引量:1
  • 5Chauvet B,Oozeer R,Bey P,et al.Conformal radiotherapy of prostatic cancer:a general review.Cancer Radiother,1999,3:393-406. 被引量:1
  • 6Morris DE,Emami B,Mauch PM,et al.Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer:an ASTRO outcomes initiative.Int J Radiat Oncol Biol Phys,2005,62:3-19. 被引量:1
  • 7Hanley J,Lumley MA,Mageras GS,et al.Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate.Int J Radiat Oncol Biol Phys,1997,37:435-444. 被引量:1
  • 8Rudat V,Schraube P,Oetzel D,et al.Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer.Int J Radiat Oncol Biol Phys,1996,35:1027-1034. 被引量:1
  • 9Bayley AJ,Catton CN,Haycocks T,et al.A randomized trial of supine vs.prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.Radiother Oncol,2004,70:37-44. 被引量:1
  • 10Weber DC,Nouet P,Rouzaud M,et al.Patient positioning in prostate radiotherapy:is prone better than supine.? Int J Radiat Oncol Biol Phys,2000,47:365-371. 被引量:1

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部